Phase 2 Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed (confirmed by lab testing of tissue) with advanced ovarian cancer, primary peritoneal cancer, or fallopian tube cancer at a late stage (Stage III or IV).
- You have had either debulking surgery (to remove as much of the cancer as possible) or a diagnostic surgery within the 3 weeks before joining the trial.
- You are between 18 and 74 years old.
- You are generally able to carry out daily activities with little to no limitation (if you are over 70, your overall health and fitness will also be assessed more closely).
- Your blood counts (measured within the past 14 days) are at an acceptable level, specifically your white blood cells and platelets.
- Your kidneys are working well enough, based on a standard kidney function test.
- You are registered with a national health care system.
- You have read, understood, and signed the consent form to take part in the trial.
Who may not be able to join:
- Your cancer has spread to areas outside the abdomen, other than the lymph nodes or the lining around the lungs.
- You have already received chemotherapy treatment for your ovarian cancer.
- Your heart is not pumping blood efficiently enough (below a certain level, confirmed by a heart scan before chemotherapy starts).
- You have had another serious cancer in the past 5 years (certain fully removed skin cancers may be acceptable — confirm with trial site).
- You are currently taking a seizure-prevention medication called phenytoin, or have recently received a live vaccine such as the yellow fever vaccine.
- You are known to be allergic to any ingredient in the study medication.
- You are unable or unwilling to follow the requirements and schedule of the study.
- You are pregnant or currently breastfeeding.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Richard VILLET, MD, Groupe Hospitalier Diaconessess Croix Saint Simon
Phone: 33 (0) 1 44 74 10 42
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Pathological complete peritoneal response (pCR)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.